Skip to content
healthcare.dev

Zubsolv

NDC 54123-914, buprenorphine hydrochloride and naloxone hydrochloride, tablet, orally disintegrating, from Orexo US, Inc..

Product NDC
54123-914
Status
Listed
Labeler
Orexo US, Inc.
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
SUBLINGUAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA204242
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/54123-914 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPRENORPHINE HYDROCHLORIDE1.4 mg/1
  • NALOXONE HYDROCHLORIDE.36 mg/1

Pharmacologic classes

Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]

Package NDCNDC-11Package
54123-914-30541230914303 BLISTER PACK in 1 CARTON (54123-914-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5f5cfcfe-d52b-49e6-8fe4-550477332dd2
  • NADAC price for package 54123091430

    GET /v1/drugs/nadac/54123091430

Use it

Look up 54123-914 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/54123-914 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 54123-914. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.